Free Trial

Aveanna Healthcare (AVAH) Competitors

Aveanna Healthcare logo
$6.47 -0.16 (-2.41%)
Closing price 04:00 PM Eastern
Extended Trading
$6.46 0.00 (-0.08%)
As of 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AVAH vs. CAI, PACS, RDNT, SHC, and OPCH

Should you be buying Aveanna Healthcare stock or one of its competitors? The main competitors of Aveanna Healthcare include Caris Life Sciences (CAI), PACS Group (PACS), RadNet (RDNT), Sotera Health (SHC), and Option Care Health (OPCH). These companies are all part of the "healthcare" industry.

How does Aveanna Healthcare compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Aveanna Healthcare (NASDAQ:AVAH) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

Aveanna Healthcare has a net margin of 9.25% compared to Caris Life Sciences' net margin of 0.00%. Aveanna Healthcare's return on equity of 481.69% beat Caris Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Caris Life SciencesN/A N/A N/A
Aveanna Healthcare 9.25%481.69%6.08%

Caris Life Sciences presently has a consensus target price of $28.86, indicating a potential upside of 52.28%. Aveanna Healthcare has a consensus target price of $10.25, indicating a potential upside of 58.42%. Given Aveanna Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe Aveanna Healthcare is more favorable than Caris Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Caris Life Sciences
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43
Aveanna Healthcare
0 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.55

Aveanna Healthcare has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Caris Life Sciences$812.03M6.60-$68.09M-$0.18N/A
Aveanna Healthcare$2.43B0.58$225.03M$1.026.34

88.0% of Aveanna Healthcare shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Caris Life Sciences had 8 more articles in the media than Aveanna Healthcare. MarketBeat recorded 8 mentions for Caris Life Sciences and 0 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.51 beat Caris Life Sciences' score of 0.18 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company Overall Sentiment
Caris Life Sciences Neutral
Aveanna Healthcare Positive

Summary

Aveanna Healthcare beats Caris Life Sciences on 13 of the 15 factors compared between the two stocks.

How does Aveanna Healthcare compare to PACS Group?

PACS Group (NYSE:PACS) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

Aveanna Healthcare has a net margin of 9.25% compared to PACS Group's net margin of 3.62%. Aveanna Healthcare's return on equity of 481.69% beat PACS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group3.62% 22.55% 3.45%
Aveanna Healthcare 9.25%481.69%6.08%

PACS Group presently has a consensus target price of $44.40, indicating a potential upside of 36.16%. Aveanna Healthcare has a consensus target price of $10.25, indicating a potential upside of 58.42%. Given Aveanna Healthcare's higher probable upside, analysts clearly believe Aveanna Healthcare is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.00
Aveanna Healthcare
0 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.55

Aveanna Healthcare has lower revenue, but higher earnings than PACS Group. Aveanna Healthcare is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B0.97$191.54M$1.2326.51
Aveanna Healthcare$2.43B0.58$225.03M$1.026.34

88.0% of Aveanna Healthcare shares are owned by institutional investors. 70.4% of PACS Group shares are owned by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

PACS Group has a beta of -0.03, indicating that its stock price is 103% less volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 1.93, indicating that its stock price is 93% more volatile than the S&P 500.

In the previous week, PACS Group had 7 more articles in the media than Aveanna Healthcare. MarketBeat recorded 7 mentions for PACS Group and 0 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.51 beat PACS Group's score of 0.39 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company Overall Sentiment
PACS Group Neutral
Aveanna Healthcare Positive

Summary

Aveanna Healthcare beats PACS Group on 8 of the 15 factors compared between the two stocks.

How does Aveanna Healthcare compare to RadNet?

RadNet (NASDAQ:RDNT) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

In the previous week, RadNet had 10 more articles in the media than Aveanna Healthcare. MarketBeat recorded 10 mentions for RadNet and 0 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.51 beat RadNet's score of 0.28 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company Overall Sentiment
RadNet Neutral
Aveanna Healthcare Positive

Aveanna Healthcare has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$2.04B2.27-$18.65M-$0.25N/A
Aveanna Healthcare$2.43B0.58$225.03M$1.026.34

Aveanna Healthcare has a net margin of 9.25% compared to RadNet's net margin of -0.91%. Aveanna Healthcare's return on equity of 481.69% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-0.91% 2.52% 0.88%
Aveanna Healthcare 9.25%481.69%6.08%

77.9% of RadNet shares are held by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

RadNet has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 1.93, indicating that its stock price is 93% more volatile than the S&P 500.

RadNet presently has a consensus target price of $88.14, indicating a potential upside of 49.28%. Aveanna Healthcare has a consensus target price of $10.25, indicating a potential upside of 58.42%. Given Aveanna Healthcare's higher possible upside, analysts clearly believe Aveanna Healthcare is more favorable than RadNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
1 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.90
Aveanna Healthcare
0 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.55

Summary

Aveanna Healthcare beats RadNet on 11 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

In the previous week, Sotera Health had 15 more articles in the media than Aveanna Healthcare. MarketBeat recorded 15 mentions for Sotera Health and 0 mentions for Aveanna Healthcare. Sotera Health's average media sentiment score of 0.75 beat Aveanna Healthcare's score of 0.51 indicating that Sotera Health is being referred to more favorably in the media.

Company Overall Sentiment
Sotera Health Positive
Aveanna Healthcare Positive

Aveanna Healthcare has higher revenue and earnings than Sotera Health. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.16B3.76$77.94M$0.2756.78
Aveanna Healthcare$2.43B0.58$225.03M$1.026.34

Aveanna Healthcare has a net margin of 9.25% compared to Sotera Health's net margin of 6.70%. Aveanna Healthcare's return on equity of 481.69% beat Sotera Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health6.70% 42.38% 6.91%
Aveanna Healthcare 9.25%481.69%6.08%

91.0% of Sotera Health shares are held by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are held by institutional investors. 15.4% of Sotera Health shares are held by company insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Sotera Health has a beta of 1.82, indicating that its stock price is 82% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 1.93, indicating that its stock price is 93% more volatile than the S&P 500.

Sotera Health presently has a consensus target price of $20.67, indicating a potential upside of 34.81%. Aveanna Healthcare has a consensus target price of $10.25, indicating a potential upside of 58.42%. Given Aveanna Healthcare's higher possible upside, analysts clearly believe Aveanna Healthcare is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70
Aveanna Healthcare
0 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.55

Summary

Sotera Health beats Aveanna Healthcare on 9 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Option Care Health?

Aveanna Healthcare (NASDAQ:AVAH) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

Aveanna Healthcare currently has a consensus target price of $10.25, indicating a potential upside of 58.42%. Option Care Health has a consensus target price of $32.08, indicating a potential upside of 50.63%. Given Aveanna Healthcare's higher probable upside, analysts plainly believe Aveanna Healthcare is more favorable than Option Care Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aveanna Healthcare
0 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.55
Option Care Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.83

88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 98.1% of Option Care Health shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by company insiders. Comparatively, 1.7% of Option Care Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Option Care Health had 37 more articles in the media than Aveanna Healthcare. MarketBeat recorded 37 mentions for Option Care Health and 0 mentions for Aveanna Healthcare. Option Care Health's average media sentiment score of 0.80 beat Aveanna Healthcare's score of 0.51 indicating that Option Care Health is being referred to more favorably in the news media.

Company Overall Sentiment
Aveanna Healthcare Positive
Option Care Health Positive

Aveanna Healthcare has a beta of 1.93, indicating that its share price is 93% more volatile than the S&P 500. Comparatively, Option Care Health has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500.

Aveanna Healthcare has higher earnings, but lower revenue than Option Care Health. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aveanna Healthcare$2.43B0.58$225.03M$1.026.34
Option Care Health$5.67B0.59$207.59M$1.2916.51

Aveanna Healthcare has a net margin of 9.25% compared to Option Care Health's net margin of 3.64%. Aveanna Healthcare's return on equity of 481.69% beat Option Care Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Aveanna Healthcare9.25% 481.69% 6.08%
Option Care Health 3.64%18.17%7.16%

Summary

Option Care Health beats Aveanna Healthcare on 10 of the 16 factors compared between the two stocks.

Get Aveanna Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVAH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVAH vs. The Competition

MetricAveanna HealthcareMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.41B$5.53B$6.25B$11.87B
Dividend YieldN/A1.44%2.73%5.21%
P/E Ratio6.3442.9029.0428.47
Price / Sales0.5822.49476.6160.94
Price / Cash9.5816.2127.6236.52
Price / Book6.963.089.676.67
Net Income$225.03M$218.81M$3.55B$332.53M
7 Day Performance-3.43%-1.87%1.70%2.01%
1 Month Performance1.41%5.05%5.62%9.20%
1 Year Performance36.50%21.23%34.42%39.59%

Aveanna Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVAH
Aveanna Healthcare
4.7187 of 5 stars
$6.47
-2.4%
$10.25
+58.4%
N/A$1.41B$2.43B6.3435,500
CAI
Caris Life Sciences
N/A$18.60
-6.7%
$28.86
+55.1%
N/A$5.26B$812.03MN/A1,846
PACS
PACS Group
4.3548 of 5 stars
$33.03
-6.4%
$44.40
+34.4%
N/A$5.19B$5.29B26.8547,455
RDNT
RadNet
2.8078 of 5 stars
$57.16
-1.0%
$88.14
+54.2%
N/A$4.47B$2.04BN/A11,264
SHC
Sotera Health
3.3783 of 5 stars
$15.50
-2.0%
$20.14
+30.0%
N/A$4.42B$1.16B57.393,000

Related Companies and Tools


This page (NASDAQ:AVAH) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners